BioCentury
ARTICLE | Company News

Management tracks

April 19, 2017 10:37 PM UTC

Cardiovascular company MyoKardia Inc. (NASDAQ:MYOK) appointed David Meeker to its board. He is stepping down at the end of June as EVP and general manager of the Genzyme unit of Sanofi (Euronext:SAN; NYSE:SNY).

Immunotherapy company Hookipa Biotech AG (Vienna, Austria) named Reinhard Kandera CFO. He was CFO at Valneva SE (Euronext:VLA; VSE:VLA)...